TY  - CHAP
AU  - Jordyn Feinstein
AU  - Muaiad Kittaneh
ED  - Sonia Maciá
Y1  - 2020-09-12
PY  - 2020
T1  - Biomarkers Progress and Therapeutic Implications in Malignant Mesothelioma
N2  - Mesothelioma is an aggressive cancer with very poor survival and lack of treatment options. This book, written by a diverse panel of experts, presents a description of the most relevant topics on epidemiology, diagnosis, biomarkers, and treatment updates, including interesting discussion on molecular mechanisms, prognostic features, and novel therapies that are either approved or under clinical development for this challenging disease. It also discusses and explains genetic biomarkers, as there may be a role for some nuclear regulatory genes and proteins in development of mesothelioma, although targeted therapies so far have had limited impact.
BT  - Mesothelioma
SP  - Ch. 6
UR  - https://doi.org/10.5772/intechopen.93564
DO  - 10.5772/intechopen.93564
SN  - 978-1-83968-155-4
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-25
ER  -